Clinical Trial Update: REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue [NA]

View source ↗

Summary

The REVITALIZE trial evaluating a telehealth intervention for women with advanced ovarian cancer and PARP-inhibitor–related fatigue has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fatigue | NA | Status: COMPLETED | Results posted: 2024-11-15